| known also as: |
NF, NFNS, Neurofibromatosis-Noonan syndrome, Neurofibromin 1, VRNF, WATS, WSS, Watson Syndrome), neurofibromatosis, type I, von Recklinghausen disease neurofibromin, Anti-Neurofibromin (NF1 |
| known also as: |
NF, NFNS, Neurofibromatosis-Noonan syndrome, Neurofibromin 1, VRNF, WATS, WSS, Watson Syndrome), neurofibromatosis, type I, von Recklinghausen disease neurofibromin, Neurofibromin (NF1 |
| known also as: |
NF, NFNS, Neurofibromatosis-Noonan syndrome, Neurofibromin 1, VRNF, WATS, WSS, Watson Syndrome), neurofibromatosis, type I, von Recklinghausen disease neurofibromin, Neurofibromin (NF1 |
| known also as: |
Neurofibromin |
| known also as: |
NF, NFNS, Neurofibromatosis-Noonan syndrome, Neurofibromin 1, VRNF, WATS, WSS, Watson Syndrome), neurofibromatosis, type I, von Recklinghausen disease neurofibromin, Anti -Neurofibromin (NF1 |
| Other names: |
Neurofibromatosis-related protein NF-1, Neurofibromin, OTTHUMP00000163771, OTTHUMP00000163772, OTTHUMP00000166089, neurofibromatosis-related protein NF-1, neurofibromin, neurofibromin 1, neurofibromin |
| Other gene names: |
DKFZp686J1293, FLJ21220, N/A, NF1, NFNS, VRNF, WSS, NF1 |
| Category: |
Antibodies |
| Clonality: |
Polyclonal |
| Immunoglobulin isotype: |
IgG |
| Clone: |
Polyclonal antibody |
| Host organism: |
Source: Human, Host: Rabbit |
| Species reactivity: |
Human |
| Specificity and cross-reactivity: |
the protein product of the NF1 tumor suppressor gene, Specific for human Neurofibromin 1 (NF1) |
| Purification method: |
Affinity Purified by affinity chromatography |
| Form/Appearance: |
0, 09% sodium azide before the addition of glycerol to 40%, Supplied as a liquid in Tris-citrate/phosphate |
| Storage and shipping: |
For maximum recovery of product, Further dilutions can be made in assay buffer, Long-term storage should be done after aliquoting the item and freezing the aliqotes at -20 degrees Celsius, Under these conditions the aliquots will be stable for at least one year if kept at -20 °, centrifuge the original vial after thawing and prior to removing the cap, C, Store at 4 degrees Celsius for short term storage |
| Tested for:: |
Immunoprecipitation (IP), Western Blot (WB) |
| Description: |
Polyclonal antibodies generally are more stable and retain their reactivity under unfavorable conditions, Polyclonal antibodies have series of advantages - larger batches can be supplied at a time, Properly used, To obtain more detailed information on productone, please, refer to the full product datasheet, the time needed for production is considerably shorter, they are inexpensive to manufacture and respectively to buy, this antibody will ensure excellent and reproducible results with guaranteed success for the applications that it is tested in, productone is a polyclonal antibody of high purity and binding affinity for the antigen that it is risen against |
| Advisory: |
For antibodies that are in liquid form or reconstituted lyophilized antibodies small amounts could become entrapped on the seal or the walls of the tube, Prior to use briefly centrifuge the vial to gather all the solution on the bottom, avoid cycles of freezing and thawing, please, In order to retain the quality and the affinity of productone unchanged |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by MBS Polyclonals_1 they should be stored frozen at - 24° |
| Gene target: |
I, NF, NFNS, Neurofibromatosis-Noonan syndrome, Neurofibromin 1, VRNF, WATS, WSS, Watson Syndrome), neurofibromatosis, von Recklinghausen disease neurofibromin, Neurofibromin (NF1 |
| Short name: |
NF, NFNS, Neurofibromatosis-Noonan syndrome, Neurofibromin 1, VRNF, WATS, WSS, Watson Syndrome) Antibody, neurofibromatosis, type I, von Recklinghausen disease neurofibromin, Neurofibromin (NF1 |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
NF, NFNS, Neurofibromatosis-Noonan syndrome, Neurofibromin 1, VRNF, WATS, WSS, Watson Syndrome) (Antibody to), classification I, neurofibromatosis, von Recklinghausen disease neurofibromin, Neurofibromin (neurofibromin 1 |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
GABAergic and biological process this GO :0032318 and regulation of Ras GTPase activity and biological process this GO :0032320 and positive regulation of Ras GTPase activity and biological process this GO :0035021 and negative regulation of Rac protein signal transduction and biological process this GO :0042060 and wound healing and biological process this GO :0042127 and regulation of cell proliferation and biological process this GO :0042992 and negative regulation of transcription factor import into nucleus and biological process this GO :0043065 and positive regulation of apoptotic process and biological process this GO :0043407 and negative regulation of MAP kinase activity and biological process this GO :0043409 and negative regulation of MAPK cascade and biological process this GO :0043473 and pigmentation and biological process this GO :0043525 and positive regulation of neuron apoptotic process and biological process this GO :0043535 and regulation of blood vessel endothelial cell migration and biological process this GO :0045124 and regulation of bone resorption and biological process this GO :0045671 and negative regulation of osteoclast differentiation and biological process this GO :0045685 and regulation of glial cell differentiation and biological process this GO :0045762 and positive regulation of adenylate cyclase activity and biological process this GO :0045765 and regulation of angiogenesis and biological process this GO :0046580 and negative regulation of Ras protein signal transduction and biological process this GO :0046929 and negative regulation of neurotransmitter secretion and biological process this GO :0048147 and negative regulation of fibroblast proliferation and biological process this GO :0048169 and regulation of long-term neuronal synaptic plasticity and biological process this GO :0048485 and sympathetic nervous system development and biological process this GO :0048593 and camera-type eye morphogenesis and biological process this GO :0048712 and negative regulation of astrocyte differentiation and biological process this GO :0048715 and negative regulation of oli this GO dendrocyte differentiation and biological process this GO :0048745 and smooth muscle tissue development and biological process this GO :0048844 and artery morphogenesis and biological process this GO :0048853 and forebrain morphogenesis and biological process this GO :0050890 and cognition and biological process this GO :0051056 and regulation of small GTPase mediated signal transduction and biological process this GO :1902043 and positive regulation of extrinsic apoptotic signaling pathway via death domain receptors and biological process this GO :2001241 and positive regulation of extrinsic apoptotic signaling pathway in absence of ligand and biological process, NF1 and IDBG-39462 and ENSG00000196712 and 102725369, NF1 and IDBG-631285 and ENSBTAG00000011829 and 280877, NFNS and VRNF and WSS, Nf1 and IDBG-203454 and ENSMUSG00000020716 and 18015, nuclei, phosphatidylcholine binding, this GO :0000165 and MAPK cascade and biological process this GO :0001649 and osteoblast differentiation and biological process this GO :0001656 and metanephros development and biological process this GO :0001666 and response to hypoxia and biological process this GO :0001889 and liver development and biological process this GO :0001937 and negative regulation of endothelial cell proliferation and biological process this GO :0001938 and positive regulation of endothelial cell proliferation and biological process this GO :0001952 and regulation of cell-matrix adhesion and biological process this GO :0001953 and negative regulation of cell-matrix adhesion and biological process this GO :0005096 and GTPase activator activity and molecular function this GO :0005099 and Ras GTPase activator activity and molecular function this GO :0005488 and binding and molecular function this GO :0005515 and protein binding and molecular function this GO :0005622 and intracellular and cellular component this GO :0005634 and nucleus and cellular component this GO :0005730 and nucleolus and cellular component this GO :0005737 and cytoplasm and cellular component this GO :0006469 and negative regulation of protein kinase activity and biological process this GO :0007154 and cell communication and biological process this GO :0007165 and signal transduction and biological process this GO :0007265 and Ras protein signal transduction and biological process this GO :0007406 and negative regulation of neuroblast proliferation and biological process this GO :0007420 and brain development and biological process this GO :0007422 and peripheral nervous system development and biological process this GO :0007507 and heart development and biological process this GO :0007519 and skeletal muscle tissue development and biological process this GO :0008285 and negative regulation of cell proliferation and biological process this GO :0008429 and phosphatidylethanolamine binding and molecular function this GO :0008542 and visual learning and biological process this GO :0008625 and extrinsic apoptotic signaling pathway via death domain receptors and biological process this GO :0014044 and Schwann cell development and biological process this GO :0014065 and phosphatidylinositol 3-kinase signaling and biological process this GO :0016020 and membrane and cellular component this GO :0016525 and negative regulation of angiogenesis and biological process this GO :0021510 and spinal cord development and biological process this GO :0021897 and forebrain astrocyte development and biological process this GO :0021915 and neural tube development and biological process this GO :0021987 and cerebral cortex development and biological process this GO :0022011 and myelination in peripheral nervous system and biological process this GO :0030036 and actin cytoskeleton organization and biological process this GO :0030198 and extracellular matrix organization and biological process this GO :0030199 and collagen fibril organization and biological process this GO :0030325 and adrenal gland development and biological process this GO :0030336 and negative regulation of cell migration and biological process this GO :0030424 and axon and cellular component this GO :0030425 and dendrite and cellular component this GO :0031210 and phosphatidylcholine binding and molecular function this GO :0031235 and intrinsic component of the cytoplasmic side of the plasma membrane and cellular component this GO :0032228 and regulation of synaptic transmission, this GO :0005096 : GTPase activator activity, this GO :0005096 : GTPase activator activity and also this GO :0005099 : Ras GTPase activator activity and also this GO :0005488 : binding and also this GO :0005515 : protein binding and also this GO :0008429 : phosphatidylethanolamine binding and also this GO :0031210 : phosphatidylcholine binding, this GO :0005099 : Ras GTPase activator activity, this GO :0005488 : binding, this GO :0005515 : protein binding, this GO :0008429 : phosphatidylethanolamine binding, this GO :0031210 : phosphatidylcholine binding, 4763, neurofibromin 1 |
| Identity: |
7765 |
| Gene: |
NF1 |
More about : NF1 |
| Long gene name: |
neurofibromin 1 |
| Synonyms name: |
neurofibromatosis von Recklinghausen disease Watson disease |
| Locus: |
17q11, 2 |
| Discovery year: |
1986-01-01 |
| Entrez gene record: |
4763 |
| Pubmed identfication: |
1715669 |
| RefSeq identity: |
NM_000267 |
| Havana BLAST/BLAT: |
OTTHUMG00000132871 |
| Locus Specific Databases: |
LOVD - Mendelian genes LRG_214 |